1. Show article details.

    Insurance Stocks Moving In Friday's Intraday Session

    Benzinga – 12:55 PM ET 08/12/2022

      According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. This article was generated by Benzinga's automated content engine and reviewed by an editor.

  2. Show article details.

    LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday

    Benzinga – 11:59 AM ET 08/12/2022

    Altimmune, Inc. jumped 28% to $17.64. B. Riley Securities maintained Altimmune with a Buy and raised the price target from $21 to $26.      

  3. Show article details.

    BRIEF-Lemonade Selects Mitchell's Solutions To Support Entry Into $300-Billion U.S. Auto Insurance Market

    Reuters – 10:00 AM ET 08/11/2022

    Lemonade Inc (LMND): * LEMONADE SELECTS MITCHELL'S SOLUTIONS TO SUPPORT ENTRY INTO THE $300 BILLION U.S. AUTO INSURANCE MARKET Source text for Eikon: Further company coverage:

  4. Show article details.

    What 4 Analyst Ratings Have To Say About Lemonade

    Benzinga – 5:27 PM ET 08/10/2022

      Within the last quarter, Lemonade has observed the following analyst ratings: In the last 3 months, 4 analysts have offered 12-month price targets for Lemonade. Below is a summary of how these 4 analysts rated Lemonade over the past 3 months.

  5. Show article details.

    Insurance Stocks Moving In Wednesday's Intraday Session

    Benzinga – 12:47 PM ET 08/10/2022

      According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. This article was generated by Benzinga's automated content engine and reviewed by an editor.

  6. Show article details.

    Where Lemonade Stands With Analysts

    Benzinga – 8:04 AM ET 08/10/2022

      Analysts have provided the following ratings for Lemonade within the last quarter: These 4 analysts have an average price target of $23.25 versus the current price of Lemonade at $28.16, implying downside. Below is a summary of how these 4 analysts rated Lemonade over the past 3 months.

  7. Show article details.

    Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

    Benzinga – 3:52 AM ET 08/10/2022

  8. Show article details.

    Why Lemonade Stock Is Surging Today: 'We Are Fast Approaching The Tipping Point'

    Benzinga – 2:41 PM ET 08/09/2022

    Lemonade Inc shares are trading higher Tuesday after the company reported better-than-expected financial results and issued guidance above analyst estimates. Lemonade reported second-quarter revenue of $50 million, which beat the estimate of $47.7 million, according to Benzinga Pro.

  9. Show article details.

    Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

    Benzinga – 1:26 PM ET 08/09/2022

    Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

  10. Show article details.

    Insurance Stocks Moving In Tuesday's Intraday Session

    Benzinga – 12:47 PM ET 08/09/2022

      According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. This article was generated by Benzinga's automated content engine and reviewed by an editor.

  11. Show article details.

    Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday

    Benzinga – 11:39 AM ET 08/09/2022

      Verona Pharma plc shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.      

  12. Show article details.

    Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket

    Benzinga – 5:49 AM ET 08/09/2022

      Don't forget to check out our premarket coverage here .

  13. Show article details.

    BRIEF-Lemonade Inc - QTRLY Revenue Of $50 Million Up 77%

    Reuters – 6:03 PM ET 08/08/2022

    Lemonade Inc (LMND): * QTRLY REVENUE OF $50 MILLION UP 77% * QTRLY LOSS PER SHARE $1.10. * Q2 EARNINGS PER SHARE VIEW $-1.32, REVENUE VIEW $47.7 MILLION -- REFINITIV IBES DATA. * SEES Q3 REVENUE OF $63 MILLION TO $65 MILLION. * SEES FULL YEAR 2022 REVENUE OF $236 MILLION TO $239 MILLION. * Q3 REVENUE VIEW $57.0 MILLION -- REFINITIV IBES DATA.

  14. Show article details.

    Lemonade Shares Soar Post Q2 Results, Registers 77% Revenue Growth

    Benzinga – 5:33 PM ET 08/08/2022

    Lemonade Shares Soar Post Q2 Results, Registers 77% Revenue Growth

  15. Show article details.

    Recap: Lemonade Q2 Earnings

    Benzinga – 5:14 PM ET 08/08/2022

      Lemonade reported its Q2 earnings results on Monday, August 8, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Lemonade beat estimated earnings by 16.67%, reporting an EPS of $-1.1 versus an estimate of $-1.32. Revenue was up $21.80 million from the same period last year.

  16. Show article details.

    Lemonade Announces Second Quarter 2022 Financial Results

    Business Wire – 4:35 PM ET 08/08/2022

    Lemonade, Inc. (LMND) has released its second quarter 2022 financial results by posting them to its website. On Tuesday, August 9, 2022, Lemonade will host a conference call at 8:00 a.m. Eastern time to discuss the results. To register for this conference call, please use this link. Registrants will receive confirmation with dial-in details.

  17. Show article details.

    Earnings Scheduled For August 8, 2022

    Benzinga – 5:30 AM ET 08/08/2022

      ** Pyxis Tankers is likely to report earnings for its second quarter. ** Kandi Technologies Gr is projected to report earnings for its second quarter. ** Tredegar is estimated to report earnings for its second quarter. ** PowerFleet is likely to report quarterly loss at $0.12 per share on revenue of $34.36 million. ** PDS Biotechnology is projected to report earnings for its second quarter.

  18. Show article details.

    Insurtech investment drops by half in Q2-report

    Reuters – 3:30 AM ET 08/04/2022

    Global investment in insurance technology firms totalled $2.41 billion in the second quarter, down 50% from a year earlier, as investors grew nervous about frothy valuations, broker Gallagher Re said in a report on Thursday. Insurtech firms make up around 10% of the fintech sector and have seen several successful fundraisings in recent years.

  19. Show article details.

    Insurance Stocks Moving In Wednesday's Intraday Session

    Benzinga – 12:54 PM ET 08/03/2022

    According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. This article was generated by Benzinga's automated content engine and reviewed by an editor.

  20. Show article details.

    Insurance Stocks Moving In Tuesday's Intraday Session

    Benzinga – 1:02 PM ET 08/02/2022

    According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session. This article was generated by Benzinga's automated content engine and reviewed by an editor.

Page:

Today's and Upcoming Events

  • Nov
    07

    LMND to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • Aug
    08

    LMND announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.